Publications by authors named "Stephanie Shi"

Claim this Profile
A
Asthma Phenotype Progression in Children and Adolescents: A Single Center Experience.
Christine L Schuler, Stephanie Shi, Yin Zhang, Md Monir Hossain, Theresa W Guilbert

Pediatr Pulmonol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Insights into the Roles of Rho Kinase in Cancer.
Lei Wei, Michelle Surma, Stephanie Shi, Nathan Lambert-Cheatham, Jianjian Shi

Arch Immunol Ther Exp (Warsz)· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissecting the Mechanisms of Doxorubicin and Oxidative Stress-Induced Cytotoxicity: The Involvement of Actin Cytoskeleton and ROCK1.
Lei Wei, Michelle Surma, Gina Gough, Stephanie Shi, Nathan Lambert-Cheatham, Jianjian Shi

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitor.
Kai Wang, Qin Zhang, Danan Li, Keith Ching, Cathy Zhang, Stephanie Shi

Clin Cancer Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer.
Kai Wang, Siu Tsan Yuen, Jiangchun Xu, Siu Po Lee, Helen H N Yan, Stephanie T Shi, Shibing Deng

Nat Genet· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular predictors of sensitivity to the insulin-like growth factor 1 receptor inhibitor Figitumumab (CP-751,871).
Adam Pavlicek, Maruja E Lira, Nathan V Lee, Keith A Ching, Jingjing Ye, Stephanie T Shi

Mol Cancer Ther· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling.
Ho-Yeong Lim, Insuk Sohn, Shibing Deng, Jeeyun Lee, Sin Ho Jung, Stephanie Shi

Ann Surg Oncol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
Kai Wang, Ho Yeong Lim, Stephanie Shi, Jeeyun Lee, Shibing Deng

Hepatology· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735.
Kenneth E Hook, Scott J Garza, Maruja E Lira, Keith A Ching, Nathan V Lee, Stephanie T Shi

Mol Cancer Ther· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer.
Kai Wang, Junsuo Kan, Siu Tsan Yuen, Stephanie T Shi, Kent Man Chu

Nat Genet· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-nucleoside inhibitors of hepatitis C virus polymerase: current progress and future challenges.
Hui Li, Stephanie T Shi

Future Med Chem· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical characterization of PF-00868554, a potent nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.
Stephanie T Shi, Koleen J Herlihy, Joanne P Graham, Jim Nonomiya, Sadayappan V Rahavendran

Antimicrob Agents Chemother· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor.
Hui Li, John Tatlock, Angelica Linton, Javier Gonzalez, Tanya Jewell, Stephanie T Shi

J Med Chem· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of intergenotypic chimeric replicons to determine the broad-spectrum antiviral activities of hepatitis C virus polymerase inhibitors.
Koleen J Herlihy, Joanne P Graham, Robert Kumpf, Amy K Patick, Rohit Duggal, Stephanie T Shi

Antimicrob Agents Chemother· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro resistance study of AG-021541, a novel nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.
Stephanie T Shi, Koleen J Herlihy, Joanne P Graham, Shella A Fuhrman, Chau Doan

Antimicrob Agents Chemother· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allosteric inhibitors of hepatitis C polymerase: discovery of potent and orally bioavailable carbon-linked dihydropyrones.
Hui Li, Angelica Linton, John Tatlock, Javier Gonzalez, Allen Borchardt, Stephanie Shi

J Med Chem· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and structure-based optimization of novel dihydropyrones as potent HCV RNA polymerase inhibitors.
Hui Li, John Tatlock, Angelica Linton, Javier Gonzalez, Allen Borchardt, Stephanie Shi

Bioorg Med Chem Lett· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple type A/B heterogeneous nuclear ribonucleoproteins (hnRNPs) can replace hnRNP A1 in mouse hepatitis virus RNA synthesis.
Stephanie T Shi, Guann-Yi Yu, Michael M C Lai

J Virol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction with a ubiquitin-like protein enhances the ubiquitination and degradation of hepatitis C virus RNA-dependent RNA polymerase.
Lu Gao, Hong Tu, Stephanie T Shi, Ki-Jeong Lee, Miyuki Asanaka

J Virol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2.
Stephanie T Shi, Ki-Jeong Lee, Hideki Aizaki, Soon B Hwang, Michael M C Lai

J Virol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rolling circle replication of hepatitis delta virus RNA is carried out by two different cellular RNA polymerases.
Thomas B Macnaughton, Stephanie T Shi, Lucy E Modahl, Michael M C Lai

J Virol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins.
Stephanie T Shi, Stephen J Polyak, Hong Tu, Deborah R Taylor, David R Gretch

Virology· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis